ALX Oncology Holdings Inc. ALXO

Set alert

Price alert · ALXO

All alert types
1.37 USD +0.15 +12.30%

At close · Nov 2

1.39 +0.02 +1.46%

After hours · Nov 2, 4:00 PM ET

Bid
1.38 × 2
Ask
1.39 × 2
1.20 Day range 1.42
0.862 52-week range 2.66
YTD
+21.24%
1 year
-11.04%
Open
1.23
Prev close
1.22
Mkt cap
189.44M
Vol
1.61M
Avg vol
1.27M
EPS
-1.13
P/E
0.00
Div yield
0.00%
More statistics
Low
1.20
High
1.42
Forward P/E
-0.68
Beta
1.04
Short ratio
8.58
Inst. own
88.21%
Dividend
0.00
Ex-div date
Earnings
Aug 8, 2024
50-d avg
1.50
200-d avg
6.33
1y target
7.67

5D chart

Chart tools
Interval

Signals (65)
NameTimeAgo
MACD: Sell SignalNov 2, 1:05 PM15 hours ago
SMA: BearishNov 2, 12:25 PM15 hours ago
SMA: BullishNov 2, 12:15 PM16 hours ago
SMA: BearishNov 2, 12:10 PM16 hours ago
RSI: OverboughtNov 2, 11:50 AM16 hours ago
MACD: Buy SignalNov 2, 11:25 AM16 hours ago
MACD: Sell SignalNov 2, 11:05 AM17 hours ago
SMA: BearishNov 2, 10:40 AM17 hours ago
SMA: BullishNov 2, 9:50 AM18 hours ago
MACD: Buy SignalNov 2, 9:50 AM18 hours ago
SMA: BullishNov 2, 9:45 AM18 hours ago
RSI: OversoldNov 2, 9:40 AM18 hours ago
MACD: Sell SignalOct 30, 3:40 PM3 days ago
MACD: Buy SignalOct 30, 3:15 PM3 days ago
MACD: Sell SignalOct 30, 3:10 PM3 days ago
MACD: Buy SignalOct 30, 3:00 PM3 days ago
MACD: Sell SignalOct 30, 2:30 PM3 days ago
MACD: Buy SignalOct 30, 2:15 PM3 days ago
MACD: Sell SignalOct 30, 12:10 PM3 days ago
MACD: Buy SignalOct 30, 11:50 AM3 days ago

Newest 20 of 65.

Analyst view

Consensus: buy

Buy
Price target (mean) 7.67 +459.6% upside
Target (low)
2.00
Target (mean)
7.67
Target (high)
25.00
Ratings (0m) 7 4 buy · 3 hold · 0 sell
  • Strong buy2
  • Buy2
  • Hold3
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 7
  • 1 month ago 7

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

ALXO analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.38766-0.38766 – -0.38766-0.7896+50.9%00.0%1
Next quarter-0.82-0.82 – -0.82-0.7086-15.7%00.0%1
Current year-1.70-1.70 – -1.70-3.12+45.4%00.0%1
Next year-2.28-2.81 – -1.75-1.70-33.8%00.0%2

Upgrades and downgrades

The latest rating changes

ALXO analyst upgrades and downgrades
DateFirmActionFromTo
Dec 19, 2024JefferiesDowngradeBuyHold
Dec 18, 2024Cantor FitzgeraldReiteratedOverweightOverweight
Dec 18, 2024HC Wainwright & Co.ReiteratedBuyBuy
Nov 12, 2024Cantor FitzgeraldReiterated—Overweight
Aug 16, 2024UBSMaintainedBuyBuy
Aug 13, 2024HC Wainwright & Co.ReiteratedBuyBuy
Aug 12, 2024Cantor FitzgeraldReiterated—Overweight
Aug 9, 2024StifelReiteratedHoldHold
Aug 1, 2024StifelMaintainedHoldHold
Aug 1, 2024HC Wainwright & Co.ReiteratedBuyBuy
Jun 10, 2024HC Wainwright & Co.ReiteratedBuyBuy
May 29, 2024Cantor FitzgeraldReiterated—Overweight
Apr 12, 2024Cantor FitzgeraldReiterated—Overweight
Apr 10, 2024HC Wainwright & Co.ReiteratedBuyBuy
Mar 11, 2024HC Wainwright & Co.MaintainedBuyBuy
Mar 8, 2024Piper SandlerMaintainedOverweightOverweight
Mar 8, 2024StifelDowngradeBuyHold
Dec 8, 2023JefferiesUpgradeHoldBuy
Nov 14, 2023StifelMaintainedBuyBuy
Oct 11, 2023Piper SandlerMaintainedOverweightOverweight
Oct 4, 2023UBSMaintainedBuyBuy
Oct 4, 2023Cantor FitzgeraldMaintainedOverweightOverweight
Oct 3, 2023HC Wainwright & Co.ReiteratedBuyBuy
Sep 12, 2023Cantor FitzgeraldReiteratedOverweightOverweight
Aug 14, 2023Cantor FitzgeraldMaintainedOverweightOverweight
Aug 11, 2023Cantor FitzgeraldMaintainedOverweightOverweight
Aug 11, 2023Piper SandlerMaintainedOverweightOverweight
Aug 11, 2023HC Wainwright & Co.MaintainedBuyBuy
Jul 24, 2023Cantor FitzgeraldReiteratedOverweightOverweight
May 12, 2023HC Wainwright & Co.ReiteratedBuyBuy